[ad_1]
Too few doses of vaccination, hotlines that collapse: the start of vaccination in Switzerland is difficult and for scientists one thing is clear: vaccination will be a race against time.
The Federal Office of Public Health (BAG), and therefore also the head of BAG, Anne Lévy, is currently the subject of special criticism. Impatience is understandable, says Lévy in “Saturday News.”
The fact that now people want to be vaccinated is a good sign, “because hopefully the vaccine will get us out of the pandemic.” Now patience is needed, said Lévy. “The whole world wants the same Pfizer / Biontech vaccine right now. These must occur. We were the first country to receive official approval and to vaccinate as the first country in continental Europe. We can also be proud of that. “
Vaccinate from morning to night
As Lévy explained, a second batch of 230,000 doses of vaccine has now arrived in Switzerland. In addition, the approval of Moderna’s vaccine is expected in Switzerland in the coming days.
There are enough people who could vaccinate. “Now I hope the cantons are set up to not only offer this from 9 am to 5 pm, but also start early in the morning until late at night, as well as on weekends. And then we will manage, as agreed with the cantons, to vaccinate all the people who want this before June ”.
Risk groups vaccinated at the end of March
Every day before vaccines are given, it could save lives. According to Lévy, all risk groups should be vaccinated by the end of March.
The federal government provides the cantons with two computer systems: an electronic registration tool and an electronic vaccination brochure. And there is close cooperation with the cantons.
Determination of R-value very difficult
Responding to the discussion about the R-value, which indicates how many other people an infected person infects, Lévy said his determination was extremely complex. It does not give a current picture because the population does not allow itself to be sufficiently tested and there are always delays in hospital delivery data.
“There is no better number, but it’s not the only number we trust,” Lévy said. The measures taken would also always include incidence, hospital occupancy rates and deaths.
